BIB icon

ProShares Ultra NASDAQ Biotechnology

25 hedge funds and large institutions have $5.97M invested in ProShares Ultra NASDAQ Biotechnology in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 11 closing their positions.

Holders
25
Holders Change
-9
Holders Change %
-26.47%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
7
Closed
11
Calls
$3.2M
Puts
$4.3M
Net Calls
-$1.09M
Net Calls Change
+$1.58M